Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,361,296
-
Total 13F shares
-
16,266,787
-
Share change
-
-1,066,278
-
Total reported value
-
$267,555,203
-
Price per share
-
$16.45
-
Number of holders
-
44
-
Value change
-
-$17,040,529
-
Number of buys
-
21
-
Number of sells
-
17
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) as of Q3 2016
As of 30 Sep 2016,
Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,266,787 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Novo A/S, ADAMS STREET PARTNERS LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, BlackRock Advisors LLC, Rock Springs Capital Management LP, SPHERA FUNDS MANAGEMENT LTD., and venBio Select Advisor LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.